Quantification and immunolocalization of apolipoprotein E in experimental atherosclerosis

Area of Science:

• Cardiovascular Research
• Lipid Metabolism
• Immunochemistry

Background:

• Apolipoprotein E (apo E) plays a critical role in lipoprotein metabolism.
• Understanding apo E's role in atherosclerosis requires accurate quantification methods.
• Cholesterol-induced atherosclerosis models in rabbits are crucial for studying disease mechanisms.

Purpose of the Study:

• To develop and validate a radioimmunoassay for quantifying rabbit apolipoprotein E (apo E).
• To investigate plasma apo E levels and aortic accumulation in rabbits fed a cholesterol diet.
• To explore the relationship between apo E deposition and atherosclerotic lesion development.

Main Methods:

• Development of a radioimmunoassay utilizing goat anti-apo E antibodies.
• Optimization of the assay using Tween-20 to minimize non-specific binding.
• Administration of a 1% cholesterol diet to rabbits (n=6) and monitoring of plasma apo E and cholesterol levels over time.

Main Results:

• The developed radioimmunoassay accurately measured apo E, with Tween-20 essential for assay performance.
• Plasma apo E levels increased at least 10-fold within 17-20 days on a cholesterol diet, returning to baseline upon diet cessation.
• Apo E deposition was observed in atherosclerotic lesions, correlating significantly with lipid accumulation in the aorta; apo A-I was not detected in lesions.

Conclusions:

• Plasma cholesterol concentration can serve as a surrogate marker for elevated apo E in cholesterol-fed rabbits.
• Apo E, or apo E-containing lipoproteins, are implicated in the pathogenesis of atherosclerosis in this rabbit model.
• The study provides a valuable tool for further research into apo E's role in cardiovascular disease.